- 88.8k views
Pediatric Muscular Dystrophy
Pediatric muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and degeneration in children. The most common type, Duchenne muscular dystrophy (DMD), typically manifests in early childhood, often between the ages of 2 and 5. Children with this condition experience difficulty with motor functions, such as walking, climbing stairs, and maintaining balance. As the disease progresses, it can affect the heart and respiratory muscles, leading to more severe health complications. Early diagnosis and intervention, including physical therapy, medications, and sometimes surgical treatments, are crucial in managing symptoms and improving quality of life for affected children. Research into gene therapy and other advanced treatments continues to offer hope for more effective therapies in the future.
About the Speaker
Dr. Rama Krishna Cheruvu
Senior Consultant Pediatrician, Mayflower Hospital, Hyderabad
Dr. Rama Krishna Cheruvuis currently working as Senior Consultant Pediatrician, Mayflower Hospital, Hyderabad. He is a highly experienced pediatrician with over 20 years of clinical experience. Graduating as the best outgoing student and recipient of the Dr. Lavanya Mukherjee Prize from Andhra Medical College, Visakhapatnam, in 2001, Dr. [Name] also holds a postgraduate degree in Clinical Research and Regulatory Affairs from Sikkim Manipal University. As a life member of the Indian Academy of Pediatrics (IAP), Dr. [Name] actively participates in community health programs and serves as a speaker and delegate in local IAP events. Currently, Dr. [Name] is a Senior Consultant Pediatrician at Mayflower Hospital and Trinity Hospital in Hyderabad, with special interests in infectious diseases, immunization, child growth, nutrition, and adolescent counseling.
Upcoming Case Discussions
Gynaecologist’s Guide to Ovarian Cancer
Join us for a special webinar on World Ovarian Cancer Day, titled "Gynaecologist’s Guide to Ovarian Cancer." This expert-led session will delve into the latest advancements in early diagnosis, risk stratification, and evidence-based management of ovarian cancer. Tailored for gynecologists and healthcare professionals, the session will also explore real-world case discussions and multidisciplinary treatment approaches. Let’s come together to raise awareness and empower clinicians in the fight against this silent but deadly disease
Massive Transfusion Protocol
Massive Transfusion Protocol (MTP) is a standardized medical procedure activated in cases of severe hemorrhage, typically involving the rapid administration of large volumes of blood products. The goal is to restore circulating volume, maintain hemostasis, and prevent the lethal triad of hypothermia, acidosis, and coagulopathy. MTP usually involves a balanced ratio of packed red blood cells, plasma, and platelets, often in a 1:1:1 ratio. Early activation and coordination among trauma teams, laboratory services, and blood banks are essential for its success.
Sleep Apnea and Daytime Fatigue
Sleep Disorder Breathing is a term for a group of conditions with abnormal breathing patterns during sleep. This affects everyday functioning and well being.There are few types of SDB which include upper airways resistance, hypopnea, apnea, catathrenia and heavy snoring. People suffering with SDB can have daytime symptoms that result in poor sleep also. There can also be sleepiness, depressed mood, irritability and cognitive dysfunction.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Rama Krishna Cheruvu's Talks on Assimilate
- 26th-June-2024, TIME : 5:00PM TO 6:00 PM
- 0
Pediatric muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and degeneration in children. The most common type, Duchenne muscular dystrophy (DMD), typically manifests in early childhood, often between the ages of 2 and 5. Children with this condition experience difficulty with motor functions, such as walking, climbing stairs, and maintaining balance. As the disease progresses, it can affect the heart and respiratory muscles, leading to more severe health complications. Early diagnosis and intervention, including physical therapy, medications, and sometimes surgical treatments, are crucial in managing symptoms and improving quality of life for affected children. Research into gene therapy and other advanced treatments continues to offer hope for more effective therapies in the future.
- 26th-June-2024, TIME : 5:00PM TO 6:00 PM
- 0
Pediatric muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and degeneration in children. The most common type, Duchenne muscular dystrophy (DMD), typically manifests in early childhood, often between the ages of 2 and 5. Children with this condition experience difficulty with motor functions, such as walking, climbing stairs, and maintaining balance. As the disease progresses, it can affect the heart and respiratory muscles, leading to more severe health complications. Early diagnosis and intervention, including physical therapy, medications, and sometimes surgical treatments, are crucial in managing symptoms and improving quality of life for affected children. Research into gene therapy and other advanced treatments continues to offer hope for more effective therapies in the future.